Variant report
Variant | nsv609898 |
---|---|
Chromosome Location | chr8:4815582-4828351 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:4826578..4828177-chr8:4829806..4832230,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7017888 | chr8:4815582-4815583 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs569426144 | chr8:4815583-4815584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542134119 | chr8:4815590-4815591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571466323 | chr8:4815602-4815603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530395299 | chr8:4815604-4815605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548938845 | chr8:4815615-4815616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369638491 | chr8:4815633-4815634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201498516 | chr8:4815660-4815661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201949774 | chr8:4815661-4815662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs111422217 | chr8:4815665-4815666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571428269 | chr8:4815666-4815667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17071892 | chr8:4815677-4815678 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs184367135 | chr8:4815690-4815691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190573644 | chr8:4815709-4815710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372122078 | chr8:4815714-4815715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182361071 | chr8:4815750-4815751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187017068 | chr8:4815780-4815781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200254732 | chr8:4815792-4815793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570669982 | chr8:4815795-4815796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541662731 | chr8:4815809-4815810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534471599 | chr8:4815811-4815812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533314707 | chr8:4815814-4815815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564182775 | chr8:4815817-4815818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532868151 | chr8:4815820-4815821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545216190 | chr8:4815846-4815847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563566472 | chr8:4815857-4815858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530503352 | chr8:4815869-4815870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10503295 | chr8:4815873-4815874 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs28489494 | chr8:4815875-4815876 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs78381907 | chr8:4815883-4815884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560305620 | chr8:4815921-4815922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571589299 | chr8:4815956-4815957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140968126 | chr8:4815958-4815959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529492799 | chr8:4815959-4815960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557179340 | chr8:4815969-4815970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569113092 | chr8:4815975-4815976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537549630 | chr8:4815977-4815978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377585206 | chr8:4815999-4816000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190518163 | chr8:4816004-4816005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573935967 | chr8:4816012-4816013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10503296 | chr8:4816030-4816031 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs553221298 | chr8:4816053-4816054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78455631 | chr8:4816071-4816072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545325010 | chr8:4816092-4816093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563527903 | chr8:4816096-4816097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112604351 | chr8:4816097-4816098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75792893 | chr8:4816104-4816105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542670460 | chr8:4816126-4816127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145049513 | chr8:4816134-4816135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528063343 | chr8:4816146-4816147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4815200-4815800 | Enhancers | Fetal Brain Male | brain |
2 | chr8:4815800-4818000 | Weak transcription | Fetal Brain Male | brain |
3 | chr8:4816600-4817000 | Enhancers | Fetal Heart | heart |
4 | chr8:4816800-4817200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr8:4816800-4817200 | Enhancers | Esophagus | oesophagus |
6 | chr8:4817000-4817200 | Flanking Active TSS | Fetal Heart | heart |
7 | chr8:4817200-4817800 | Enhancers | Fetal Heart | heart |
8 | chr8:4818000-4818200 | Enhancers | Fetal Brain Male | brain |
9 | chr8:4818200-4818800 | Weak transcription | Fetal Brain Male | brain |
10 | chr8:4818800-4819000 | Enhancers | Fetal Brain Male | brain |
11 | chr8:4822000-4822400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr8:4824400-4824800 | Enhancers | Fetal Heart | heart |